Understanding Patient Experiences with SVT Treatments
This study is looking at how patients feel about two common treatments for Supraventricular Tachycardia (SVT), a condition where your heart beats very fast: IV adenosine and IV diltiazem. Doctors want to understand if one treatment leads to more patient satisfaction during an emergency room visit. You might be able to join if you are 18 or older, have had SVT treated with either IV adenosine or IV diltiazem in the emergency room or before arriving, and can speak English. The study aims to enroll 20 participants, but its current recruitment status is unclear.
- Study design
- This is an observational study, meaning researchers will look at existing patient experiences rather than assigning treatments. It aims to include 20 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Patient satisfaction will be assessed during your emergency department visit.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
PERceptions of Diltiazem Versus ADEnosine for Treatment of Supraventricular Tachycardia in the Emergency Department
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Patient satisfaction with SVT treatmentPrimary outcome will be assessed during ED visit
Patient satisfaction with treatment will be assessed using a Likert scale questionnaire of 1-5. Participants will indicate their satisfaction with treatment by indicating a score of 1-5, 1 being "not at all satisfied" and 5 being "extremely satisfied".